Outcome | Study ID | Measurement tool and time point | Surgical; n | Conservative; n | Effect estimatea |
Function in the long term | Agren 2013 | Composite VAS score for pain and function (0 to 100; higher scores indicate better outcome); participant‐measured scores At 12 months |
Mean (SD): 56.9 (± 26.4); 39 | Mean (SD): 54.8 (± 23.7); 37 | MD 2.10, 95% CI −9.17 to 13.37 Favours surgical treatment Analysis 2.1 |
Function in the long term | Agren 2013 | OMAS score (0 to 100; higher scores indicate better outcome) At 12 months |
Mean (SD): 62.2 (± 24.2); 39 | Mean (SD): 60.9 (± 22.8); 37 | MD 1.30, 95% CI −9.27 to 11.87 Favours surgical treatment Analysis 2.1 |
Function in the long term | Griffin 2014 | Kerr‐Atkins score (0 to 100; higher scores indicate better outcome) At 24 months |
Mean (SD): 69.8 (± 21.8); 69 | Mean (SD): 65.7 (± 23.7); 74 | MD 4.10, 95% CI −3.36 to 11.56 Favours surgical treatment Analysis 2.1 |
Function in the long term | Kamath 2021 | MRS (0 to 100; higher scores indicate better outcome) At 1 year |
Mean (SD): 74.783 (± 11.229); 30 | Mean (SD): 57.368 (± 7.335); 31 | MD 17.41, 95% CI 12.64 to 22.19; 61 fractures (6 bilateral) Favours surgical treatment Analysis 2.1 |
Function in the long term | Kamath 2021 | VASb (lower scores indicate better outcome; inverted in analysis) At 1 year |
Mean (SD): 3.348 (± 1.369); 30 | Mean (SD): 4.944 (± 0.802); 31 | MD 1.60, 95% CI 1.03 to 2.16; 61 fractures (6 bilateral) Favours surgical treatment Analysis 2.1 |
Function in the long term | Pandey 2018 | VAS: combined pain and function measure (0 to 100; higher scores indicate better outcome) At 6 months |
Mean (SD): 56.73 (± 6.61); 22 | Mean (SD): 54 (± 5.19); 20 | MD 2.73, 95% CI −0.85 to 6.31 Favours surgical treatment Analysis 2.1 |
Chronic pain | Agren 2013 | VAS during weight‐bearing At 1 year |
Mean (SD): 2.3 (± 2.1); 39 | Mean (SD): 2.6 (± 1.6); 37 | MD −0.30, 95% CI −1.14 to 0.54 Favours surgical treatment Analysis 2.2 |
HRQoL | Agren 2013 | SF‐36 mental health score At 1 year |
Mean (SD): 52.5 (± 23.3); 39 | Mean (SD): 50.5 (± 21.9); 37 | MD 2.00, 95% CI −8.16 to 12.16 Favours surgical treatment Analysis 2.3 |
HRQoL | Griffin 2014 | EQ‐5D At 2 years |
Mean (SD): 0.72 (± 0.22); 59 | Mean (SD): 0.66 (± 0.27); 62 | MD 0.06, 95% CI −0.03 to 0.15 Favour surgical treatment Analysis 2.3 |
HRQoL | Griffin 2014 | SF‐36 mental health score At 2 years |
Mean (SD): 53.4 (± 11.4); 54 | Mean (SD): 53.6 (± 12.3); 62 | MD −0.20, 95% CI −4.51 to 4.11 Favours non‐surgical treatment Analysis 2.3 |
Return to work | Parmar 1993 | Return to same work At 1 year |
Events: 19; 25 | Events: 21; 31 | RR 1.12, 95% CI 0.81 to 1.56 Favours surgical treatment Analysis 2.4 |
Return to work | Thordarson 1996 | Return to same work Within 2 years |
Events: 12; 15 | Events: 4; 11 | RR 2.20, 95% CI 0.97 to 5.00 Favours surgical treatment Analysis 2.4 |
Return to leisure activity | Parmar 1993 | Return to previous recreation level At 1 year |
Events: 16; 25 | Events: 23; 31 | RR 0.86, 95% CI 0.60 to 1.24 Favours non‐surgical treatment Analysis 2.4 |
Return to leisure activity | Thordarson 1996 | No limitations on daily or recreational activities Within 2 years |
Events: 13; 15 | Events: 5; 11 | RR 1.91, 95% CI 0.97 to 3.75 Favours surgical treatment Analysis 2.4 |